当前位置:首页 >英文主页 >中英对照 > 中译版报告详情

艾意凯咨询:2025迎接治愈的曙光白皮书:精准医学新纪元:亚太地区能否把握治愈革命?(中国版)(中译版)(30页).pdf

上传人: 白**** 编号:731909 2025-07-23 30页 7.96MB

下载:

1、1 On the Cusp of a CureIs Asia Pacific Ready for the Precision Era?China1 L.E.K.Consulting|On the Cusp of a CureOn the Cusp of a CureIs Asia Pacific Ready for the Precision Era?L.E.K.Consulting is a registered trademark of L.E.K.Consulting LLC.All other products and brands mentioned in this document

2、 are properties of their respective owners.2025 L.E.K.Consulting LLC32 L.E.K.Consulting|On the Cusp of a CureL.E.K.Consulting|On the Cusp of a CureAcknowledgements L.E.K.Consulting would like to acknowledge the contributions of all the Advisory Committee members who have provided critical insights i

3、nto the development of this report.Specifically,their contributions have guided the assessment of barriers facing the adoption of precision therapies investigated and recommendations to addressing these barriers.NamePositionOrganisation AustraliaDavid ThomasChief Scientific OfficerOmicoJaala Pulford

4、Chair of the BoardMTPConnectChristine CockburnCEORare Cancers AustraliaChinaBaorong YuProfessor and market access key opinion leaderUniversity of International Business and EconomicsAndy MokHead of ChinaGuardant HealthKevin HuangFounder and presidentChina Organization for Rare Disorders(CORD)Caicun

5、ZhouProfessor and lung cancer key opinion leaderSchool of Medicine,Tongji UniversityJapanTeruyuki KatoriRepresentative Director Specially Appointed ProfessorFuture Institute Wolong,General Incorporated Association Graduate School of Social Sciences,University of HyogoDaisuke SatoProfessorFujita Heal

6、th universityManabu MutoProfessorKyoto University Graduate School of MedicineMasahiro MiyakeProfessorKyoto University HospitalNaomi SakuraiFounder and CEOCancer Solutions Keisuke ShimizuLeader Lung cancer HER2 HER HERSouth KoreaPaul LeeFormer GMGilead Sciences KoreaJin-Ah KimAdvocate for rare diseas

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
根据报告的内容,本文主要讨论了精准医疗在中国的发展现状和前景。关键点如下: 1. **精准医疗的定义**:包括细胞疗法、基因疗法、靶向抗体疗法和药物-设备组合疗法等,旨在为患者提供更个性化的诊断和治疗。 2. **中国精准医疗发展**:政府高度重视,投入大量资金支持精准医疗研发,并出台多项政策支持创新药物发展。 3. **精准医疗的益处**:预计2025-2035年,精准医疗将使约1050万中国患者受益,延长约920万年的预期寿命,并减轻约950-1050万护理人员的负担。 4. **经济和社会效益**:预计精准医疗将为中国节省约2160亿元人民币的医疗费用,并带动约1450亿元人民币的投资和14.2万个高技能就业岗位。 5. **面临的挑战**:包括监管和报销路径不明确、患者和医护人员认知不足、以及医疗基础设施和投资不足等。 6. **建议**:加强监管和报销政策,提高精准医疗认知,改善医疗基础设施,促进公私合作,以推动精准医疗的发展。
中国准备好迎接精准医疗时代了吗? 精准医疗将如何改变中国医疗体系? 中国如何克服精准医疗发展的障碍?
客服
商务合作
小程序
服务号
折叠